291 related articles for article (PubMed ID: 7970158)
1. Synaptic and neuritic alterations during the progression of Alzheimer's disease.
Masliah E; Mallory M; Hansen L; DeTeresa R; Alford M; Terry R
Neurosci Lett; 1994 Jun; 174(1):67-72. PubMed ID: 7970158
[TBL] [Abstract][Full Text] [Related]
2. Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus.
Masliah E; Honer WG; Mallory M; Voigt M; Kushner P; Hansen L; Terry R
Acta Neuropathol; 1994; 87(2):135-42. PubMed ID: 8171963
[TBL] [Abstract][Full Text] [Related]
3. Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions.
Cabalka LM; Hyman BT; Goodlett CR; Ritchie TC; Van Hoesen GW
Neurobiol Aging; 1992; 13(2):283-91. PubMed ID: 1522944
[TBL] [Abstract][Full Text] [Related]
4. Patterns of aberrant sprouting in Alzheimer's disease.
Masliah E; Mallory M; Hansen L; Alford M; Albright T; DeTeresa R; Terry R; Baudier J; Saitoh T
Neuron; 1991 May; 6(5):729-39. PubMed ID: 1827266
[TBL] [Abstract][Full Text] [Related]
5. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease.
Wakabayashi K; Honer WG; Masliah E
Brain Res; 1994 Dec; 667(1):24-32. PubMed ID: 7895080
[TBL] [Abstract][Full Text] [Related]
6. Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer's disease.
Kobro-Flatmoen A; Nagelhus A; Witter MP
Neurobiol Dis; 2016 Sep; 93():172-83. PubMed ID: 27195475
[TBL] [Abstract][Full Text] [Related]
7. Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease.
Kaufmann WA; Barnas U; Humpel C; Nowakowski K; DeCol C; Gurka P; Ransmayr G; Hinterhuber H; Winkler H; Marksteiner J
Eur J Neurosci; 1998 Mar; 10(3):1084-94. PubMed ID: 9753176
[TBL] [Abstract][Full Text] [Related]
8. Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease.
Masliah E; Hansen L; Albright T; Mallory M; Terry RD
Acta Neuropathol; 1991; 81(4):428-33. PubMed ID: 1903014
[TBL] [Abstract][Full Text] [Related]
9. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain.
Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ
Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760
[TBL] [Abstract][Full Text] [Related]
10. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Alzheimer-related neuritic plaques: AT8 immunoreactive dystrophic neurites precede argyrophilic neurites in plaques of the entorhinal region, hippocampal formation, and amygdala.
Yilmazer-Hanke DM
Clin Neuropathol; 1998; 17(4):194-8. PubMed ID: 9707333
[TBL] [Abstract][Full Text] [Related]
12. Synaptic alterations in the vestibulocerebellar system in Alzheimer's disease--a Golgi and electron microscope study.
Baloyannis SJ; Manolidis SL; Manolidis LS
Acta Otolaryngol; 2000 Mar; 120(2):247-50. PubMed ID: 11603783
[TBL] [Abstract][Full Text] [Related]
13. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
Yilmazer-Hanke DM; Hanke J
Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
[TBL] [Abstract][Full Text] [Related]
14. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
Thal DR; Härtig W; Schober R
J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease.
Masliah E; Mallory M; Deerinck T; DeTeresa R; Lamont S; Miller A; Terry RD; Carragher B; Ellisman M
J Neuropathol Exp Neurol; 1993 Nov; 52(6):619-32. PubMed ID: 8229081
[TBL] [Abstract][Full Text] [Related]
16. Synaptic pathology of Alzheimer's disease.
Lassmann H; Fischer P; Jellinger K
Ann N Y Acad Sci; 1993 Sep; 695():59-64. PubMed ID: 8239314
[TBL] [Abstract][Full Text] [Related]
17. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease.
Heinonen O; Soininen H; Sorvari H; Kosunen O; Paljärvi L; Koivisto E; Riekkinen PJ
Neuroscience; 1995 Jan; 64(2):375-84. PubMed ID: 7700527
[TBL] [Abstract][Full Text] [Related]
18. Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment.
King DL; Arendash GW
Brain Res; 2002 Feb; 926(1-2):58-68. PubMed ID: 11814407
[TBL] [Abstract][Full Text] [Related]
19. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
Cras P; Kawai M; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7552-6. PubMed ID: 1652752
[TBL] [Abstract][Full Text] [Related]
20. Synaptophysin immunoreactivity in Pick's disease: comparison with Alzheimer's disease and dementia with Lewy bodies.
Lippa CF
Am J Alzheimers Dis Other Demen; 2004; 19(6):341-4. PubMed ID: 15633942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
